CRISPR gene editing has cured sickle cell in a few dozen patients, but the therapy costs nearly $2 million per person. My cousin, a carrier, told me he'd rather see basic prenatal screening expanded than chase these high-tech fixes. Is it ethical to pour billions into gene therapies that only the wealthy or insured can access?